Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:2621-2627
Published online before print May 7, 2007, doi: 10.1161/CIRCULATIONAHA.106.641654
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
115/20/2621    most recent
CIRCULATIONAHA.106.641654v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lavi, S.
Right arrow Articles by Lerman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lavi, S.
Right arrow Articles by Lerman, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease
*Smoking
Related Collections
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2007;115:2621-2627.)
© 2007 American Heart Association, Inc.


Coronary Heart Disease

Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease

Shahar Lavi, MD; Abhiram Prasad, MD; Eric H. Yang, MD; Verghese Mathew, MD; Robert D. Simari, MD; Charanjit S. Rihal, MD; Lilach O. Lerman, MD, PhD; Amir Lerman, MD

From the Division of Cardiovascular Diseases (S.L., A.P., E.H.Y., V.M., R.D.S., C.S.R., A.L.) and Division of Nephrology and Hypertension (L.O.L.), Mayo College of Medicine, Rochester, Minn.

Correspondence to Amir Lerman, MD, Division of Cardiovascular Diseases, Mayo Clinic, Mary Brigh 4-523, First St SW, Rochester, MN 55905. E-mail Lerman.Amir{at}mayo.edu

Received May 24, 2006; accepted March 21, 2007.

Background— Smoking is a major risk factor for cardiovascular events. One of the potential mechanisms may be related to both coronary endothelial dysfunction and increased inflammatory response. The present study was designed to test the hypothesis that smoking is associated with epicardial coronary endothelial dysfunction and inflammation.

Methods and Results— Coronary endothelial function in response to acetylcholine was assessed in 881 patients (115 current smokers and 766 nonsmokers, including 314 previous smokers). Smokers were significantly younger than nonsmokers (43±1 versus 51±1 years, P<0.0001), had more epicardial vasoconstriction in response to intracoronary acetylcholine (–19±2% versus –14±1% change in coronary artery diameter, P=0.03), and were more likely than nonsmokers to have epicardial endothelial dysfunction (46% versus 35%, P=0.005), but their microvascular endothelial function was intact. Smokers had higher white blood cell counts than nonsmokers (7.7±0.2 versus 6.6±0.1x109/L, P<0.0001), higher myeloperoxidase (156±19 versus 89±8 ng/mL), higher lipoprotein-associated phospholipase A2 (242±12 versus 215±5 ng/mL), and higher levels of intracellular adhesion molecule (283±14 versus 252±5 ng/mL). There were no differences in the levels of C-reactive protein, fibrinogen, or vascular cell adhesion molecule between the groups.

Conclusion— Young smokers are characterized by epicardial coronary endothelial dysfunction, preserved microvascular endothelial function, and increased levels of inflammatory biomarkers and oxidative stress. The present study provides further information regarding the potential mechanisms by which smoking contributes to cardiovascular events.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Eur Heart JHome page
E. Raichlin, A. Prasad, W. K. Kremers, B. S. Edwards, C. S. Rihal, A. Lerman, and S. S. Kushwaha
Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients
Eur. Heart J., June 1, 2009; 30(11): 1356 - 1363.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Nakamura, M. Kimura, C. Goto, K. Noma, M. Yoshizumi, K. Chayama, Y. Kihara, and Y. Higashi
Cigarette Smoking Abolishes Ischemic Preconditioning-Induced Augmentation of Endothelium-Dependent Vasodilation
Hypertension, April 1, 2009; 53(4): 674 - 681.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
S. Lavi, J. P. McConnell, R. Lavi, G. W. Barsness, C. S. Rihal, G. D. Novak, L. O. Lerman, and A. Lerman
Association Between the Paraoxonase-1 192Q>R Allelic Variant and Coronary Endothelial Dysfunction in Patients With Early Coronary Artery Disease
Mayo Clin. Proc., February 1, 2008; 83(2): 158 - 164.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Lavi, E. H. Yang, A. Prasad, V. Mathew, G. W. Barsness, C. S. Rihal, L. O. Lerman, and A. Lerman
The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans
Hypertension, January 1, 2008; 51(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
JWatch GeneralHome page
Smoking and Endothelial Dysfunction
Journal Watch (General), June 19, 2007; 2007(619): 4 - 4.
[Full Text]